Literature DB >> 29426014

Network Analysis of UBE3A/E6AP-Associated Proteins Provides Connections to Several Distinct Cellular Processes.

Gustavo Martínez-Noël1, Katja Luck2, Simone Kühnle1, Alice Desbuleux3, Patricia Szajner1, Jeffrey T Galligan1, Diana Rodriguez1, Leon Zheng1, Kathleen Boyland1, Flavian Leclere1, Quan Zhong2, David E Hill2, Marc Vidal4, Peter M Howley5.   

Abstract

Perturbations in activity and dosage of the UBE3A ubiquitin-ligase have been linked to Angelman syndrome and autism spectrum disorders. UBE3A was initially identified as the cellular protein hijacked by the human papillomavirus E6 protein to mediate the ubiquitylation of p53, a function critical to the oncogenic potential of these viruses. Although a number of substrates have been identified, the normal cellular functions and pathways affected by UBE3A are largely unknown. Previously, we showed that UBE3A associates with HERC2, NEURL4, and MAPK6/ERK3 in a high-molecular-weight complex of unknown function that we refer to as the HUN complex (HERC2, UBE3A, and NEURL4). In this study, the combination of two complementary proteomic approaches with a rigorous network analysis revealed cellular functions and pathways in which UBE3A and the HUN complex are involved. In addition to finding new UBE3A-associated proteins, such as MCM6, SUGT1, EIF3C, and ASPP2, network analysis revealed that UBE3A-associated proteins are connected to several fundamental cellular processes including translation, DNA replication, intracellular trafficking, and centrosome regulation. Our analysis suggests that UBE3A could be involved in the control and/or integration of these cellular processes, in some cases as a component of the HUN complex, and also provides evidence for crosstalk between the HUN complex and CAMKII interaction networks. This study contributes to a deeper understanding of the cellular functions of UBE3A and its potential role in pathways that may be affected in Angelman syndrome, UBE3A-associated autism spectrum disorders, and human papillomavirus-associated cancers.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angelman syndrome; autism; cervical cancer; human papillomavirus; proteomics

Mesh:

Substances:

Year:  2018        PMID: 29426014      PMCID: PMC5866790          DOI: 10.1016/j.jmb.2018.01.021

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  182 in total

1.  A human interactome in three quantitative dimensions organized by stoichiometries and abundances.

Authors:  Marco Y Hein; Nina C Hubner; Ina Poser; Jürgen Cox; Nagarjuna Nagaraj; Yusuke Toyoda; Igor A Gak; Ina Weisswange; Jörg Mansfeld; Frank Buchholz; Anthony A Hyman; Matthias Mann
Journal:  Cell       Date:  2015-10-22       Impact factor: 41.582

2.  Mass spectrometric characterization of the affinity-purified human 26S proteasome complex.

Authors:  Xiaorong Wang; Chi-Fen Chen; Peter R Baker; Phang-lang Chen; Peter Kaiser; Lan Huang
Journal:  Biochemistry       Date:  2007-02-27       Impact factor: 3.162

3.  A yeast three-hybrid method to clone ternary protein complex components.

Authors:  J Zhang; S Lautar
Journal:  Anal Biochem       Date:  1996-11-01       Impact factor: 3.365

4.  Neuronal Activity and CaMKII Regulate Kinesin-Mediated Transport of Synaptic AMPARs.

Authors:  Frédéric J Hoerndli; Rui Wang; Jerry E Mellem; Angy Kallarackal; Penelope J Brockie; Colin Thacker; David M Madsen; Andres V Maricq
Journal:  Neuron       Date:  2015-04-02       Impact factor: 17.173

5.  ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.

Authors:  Weiwen Long; Charles E Foulds; Jun Qin; Jian Liu; Chen Ding; David M Lonard; Luisa M Solis; Ignacio I Wistuba; Jun Qin; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

6.  Ampakines promote spine actin polymerization, long-term potentiation, and learning in a mouse model of Angelman syndrome.

Authors:  Michel Baudry; Eniko Kramar; Xiaobo Xu; Homera Zadran; Stephanie Moreno; Gary Lynch; Christine Gall; Xiaoning Bi
Journal:  Neurobiol Dis       Date:  2012-04-16       Impact factor: 5.996

7.  Role of ubiquitin and the HPV E6 oncoprotein in E6AP-mediated ubiquitination.

Authors:  Franziska Mortensen; Daniel Schneider; Tanja Barbic; Anna Sladewska-Marquardt; Simone Kühnle; Andreas Marx; Martin Scheffner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

Review 8.  Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression.

Authors:  Karine Lefort; G Paolo Dotto
Journal:  Semin Cancer Biol       Date:  2004-10       Impact factor: 15.707

Review 9.  mTOR complexes in neurodevelopmental and neuropsychiatric disorders.

Authors:  Mauro Costa-Mattioli; Lisa M Monteggia
Journal:  Nat Neurosci       Date:  2013-10-28       Impact factor: 24.884

10.  Pooled-matrix protein interaction screens using Barcode Fusion Genetics.

Authors:  Nozomu Yachie; Evangelia Petsalaki; Joseph C Mellor; Jochen Weile; Yves Jacob; Marta Verby; Sedide B Ozturk; Siyang Li; Atina G Cote; Roberto Mosca; Jennifer J Knapp; Minjeong Ko; Analyn Yu; Marinella Gebbia; Nidhi Sahni; Song Yi; Tanya Tyagi; Dayag Sheykhkarimli; Jonathan F Roth; Cassandra Wong; Louai Musa; Jamie Snider; Yi-Chun Liu; Haiyuan Yu; Pascal Braun; Igor Stagljar; Tong Hao; Michael A Calderwood; Laurence Pelletier; Patrick Aloy; David E Hill; Marc Vidal; Frederick P Roth
Journal:  Mol Syst Biol       Date:  2016-04-22       Impact factor: 11.429

View more
  14 in total

1.  UBE3A regulates the transcription of IRF, an antiviral immunity.

Authors:  Ryohei Furumai; Kota Tamada; Xiaoxi Liu; Toru Takumi
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

2.  Angelman syndrome-associated point mutations in the Zn2+-binding N-terminal (AZUL) domain of UBE3A ubiquitin ligase inhibit binding to the proteasome.

Authors:  Simone Kühnle; Gustavo Martínez-Noël; Flavien Leclere; Sebastian D Hayes; J Wade Harper; Peter M Howley
Journal:  J Biol Chem       Date:  2018-09-26       Impact factor: 5.157

3.  Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways.

Authors:  S Jesse Lopez; Benjamin I Laufer; Ulrika Beitnere; Elizabeth L Berg; Jill L Silverman; Henriette O'Geen; David J Segal; Janine M LaSalle
Journal:  Hum Mol Genet       Date:  2019-11-15       Impact factor: 6.150

Review 4.  Protein Interaction Network Biology in Neuroscience.

Authors:  Avik Basu; Peter Ea Ash; Benjamin Wolozin; Andrew Emili
Journal:  Proteomics       Date:  2020-12-29       Impact factor: 3.984

5.  A cross-species spatiotemporal proteomic analysis identifies UBE3A-dependent signaling pathways and targets.

Authors:  Nikhil J Pandya; Sonja Meier; Stefka Tyanova; Marco Terrigno; Congwei Wang; A Mattijs Punt; E J Mientjes; Audrey Vautheny; Ben Distel; Thomas Kremer; Ype Elgersma; Ravi Jagasia
Journal:  Mol Psychiatry       Date:  2022-03-09       Impact factor: 13.437

6.  UBE3A deletion enhances the efficiency of immunotherapy in non-small-cell lung cancer.

Authors:  Nan Zhang; Jie Shen; Lanying Gou; Manming Cao; Weimin Ding; Peng Luo; Jian Zhang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

7.  Analysis of ubiquitin recognition by the HECT ligase E6AP provides insight into its linkage specificity.

Authors:  Lena K Ries; Bodo Sander; Kirandeep K Deol; Marie-Annick Letzelter; Eric Robert Strieter; Sonja Lorenz
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

Review 8.  Molecular Evolution, Neurodevelopmental Roles and Clinical Significance of HECT-Type UBE3 E3 Ubiquitin Ligases.

Authors:  Mateusz C Ambrozkiewicz; Katherine J Cuthill; Dermot Harnett; Hiroshi Kawabe; Victor Tarabykin
Journal:  Cells       Date:  2020-11-10       Impact factor: 6.600

9.  Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models.

Authors:  Kai-Chun Cheng; Yingxiao Li; Wei-Ting Chang; Zhih-Cherng Chen; Juei-Tang Cheng; Cheng-Chia Tsai
Journal:  J Food Drug Anal       Date:  2018-08-24       Impact factor: 6.157

Review 10.  UBE3A: An E3 Ubiquitin Ligase With Genome-Wide Impact in Neurodevelopmental Disease.

Authors:  Simon Jesse Lopez; David J Segal; Janine M LaSalle
Journal:  Front Mol Neurosci       Date:  2019-01-04       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.